ArticleOncoimmunology

Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses

Soley Thordardottir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.